Canada Pension Plan Investment Board
PAND

Canada Pension Plan Investment Board’s Pandion Therapeutics Inc. Common Stock PAND Stock Holding History

Canada Pension Plan Investment Board’s Portfolio PAND Stock Details PAND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-62,000
Closed -$3.72M – 1450
2021
Q1 		$3.72M Buy
62,000
+42,000
+210% +$1.52M ﹤0.01% 697
2020
Q4 		$297K Sell
20,000
-30,000
-60% -$417K ﹤0.01% 1198
2020
Q3 		$573K Buy
+50,000
New +$855K ﹤0.01% 813

Canada Pension Plan Investment Board's PAND Position: Q2 2021 in Review

Canada Pension Plan Investment Board sold out of Pandion Therapeutics Inc. Common Stock (PAND) in Q2 2021, closing a stake of 62,000 shares — an estimated $3.72M sold.

Canada Pension Plan Investment Board first reported a position in PAND in Q3 2020 and held it in 3 quarters. The position peaked at $3.72M in Q1 2021. 0 funds tracked by Wall St. Rank hold PAND as of Q2 2021.

  • Canada Pension Plan Investment Board reported no remaining Pandion Therapeutics Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Canada Pension Plan Investment Board sold 62,000 Pandion Therapeutics Inc. Common Stock shares in Q2 2021, an estimated $3.72M.
  • Canada Pension Plan Investment Board first reported a position in Pandion Therapeutics Inc. Common Stock in Q3 2020 and held it in 3 quarters.
  • Canada Pension Plan Investment Board's Pandion Therapeutics Inc. Common Stock position peaked at $3.72M in Q1 2021.
  • 0 funds tracked by Wall St. Rank held Pandion Therapeutics Inc. Common Stock as of Q2 2021.

Based on Canada Pension Plan Investment Board's 13F filing for Q2 2021, filed 16 Aug 2021.